ArticleNature communications2023

Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer.

Xijiao Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.